Skip to main content

Advertisement

SpringerLink
Log in

Social Disparities in the Diagnosis and Care of Lower Urinary Tract Dysfunction

  • Outcomes in Functional Urology (A Cameron, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To critically evaluate the recent literature on the impact of social disparities on the diagnosis and treatment in the care of lower urinary tract dysfunction (LUTD).

Recent Findings

Understanding the impact of racial and social disparities in patients with LUTD has recently been an area of great interest. Global patient diversity is steadily increasing. Studies investigating the links between socio-economic status (SES) and other cultural factors are becoming ubiquitous in urologic research. Due to increased reporting, the relationships between racial and social disparities and their influence on LUTD are finally being identified.

Summary

Patient race, ethnicity, and SES appear to have a significant effect on the prevalence, access to care, and the efficacy of treatment provided for LUTD. Social and racial disparities are unique in their burden to patients based on the symptomology and the LUTD experienced. Lower SES and being a non-White minority are commonly associated with increased prevalence, worse symptoms, and suboptimal care in LUTD. Patient-centered care which is inclusive of patient race, ethnicity, and SES is crucial in providing appropriate urological care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Pang R. Introductory chapter: lower urinary tract dysfunction at a glance. In: Pang R, editor. Lower Urinary Tract Dysfunction - From Evidence to Clinical Practice, IntechOpen; 2020. https://doi.org/10.5772/intechopen.90931.

  2. International Continence Society. Lower urinary tract symptom (LUTS). n.d. Accessed: May 19, 2022. [Online]. Available: https://www.ics.org/glossary/symptom/lowerurinarytractsymptomluts.

  3. Irwin DE, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–15. https://doi.org/10.1016/j.eururo.2006.09.019.

    Article  Google Scholar 

  4. Coyne KS, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the epidemiology of LUTS (EpiLUTS) study. BJU Int. 2009;104(3):352–60. https://doi.org/10.1111/j.1464-410X.2009.08427.x.

    Article  Google Scholar 

  5. Kogan MI, Zachoval R, Özyurt C, Schäfer T, Christensen N. Epidemiology and impact of urinary incontinence, overactive bladder, and other lower urinary tract symptoms: results of the EPIC survey in Russia, Czech Republic, and Turkey. Curr Med Res Opin. 2014;30(10):2119–30. https://doi.org/10.1185/03007995.2014.934794.

    Article  Google Scholar 

  6. Chapple C, et al. Prevalence of lower urinary tract symptoms in China, Taiwan, and South Korea: results from a cross-sectional, population-based study. Adv Ther. 2017;34(8):1953–65. https://doi.org/10.1007/s12325-017-0577-9.

    Article  Google Scholar 

  7. • Akbar A, et al. Racial differences in urinary incontinence prevalence, overactive bladder and associated bother among men: the multi-ethnic study of atherosclerosis. J Urol. 2021;205(2):524–31. https://doi.org/10.1097/JU.0000000000001353. This study examined the association of race/ethnicity with urinary incontinence subtypes and overactive bladder using a cross-sectional analysis of data from the Multi-Ethnic Study of Atherosclerosis.

    Article  Google Scholar 

  8. • Gonzalez DC, Khorsandi S, Mathew M, Enemchukwu E, Syan R. A systematic review of racial/ethnic disparities in female pelvic floor disorders. Urology. 2021; S0090–4295(21)00907–9. https://doi.org/10.1016/j.urology.2021.09.018. This systematic review of racial and ethnic disparities in female pelvic floor disorders summarized the key differences in the prevalence of disorders associated with lower urinary tract dysfunction.

  9. Braveman P. What are health disparities and health equity? We Need to Be Clear. Public Health Rep. 2014;129(1_suppl2):5–8. https://doi.org/10.1177/00333549141291S203.

    Article  Google Scholar 

  10. Daugherty M, Ginzburg N, Byler T. Prevalence of nocturia in United States women: results from National Health and Nutrition Examination Survey. Female Pelvic Med Reconstr Surg. 2021;27(1):e52–8. https://doi.org/10.1097/SPV.0000000000000792.

    Article  Google Scholar 

  11. Burgio KL, et al. Prevalence and correlates of nocturia in community-dwelling older adults: prevalence and correlates of nocturia in older adults. J Am Geriatr Soc. 2010;58(5):861–6. https://doi.org/10.1111/j.1532-5415.2010.02822.x.

    Article  Google Scholar 

  12. Rubach A, Balasubramaniam K, Elnegaard S, Larsen SE, Jarbøl DE. Barriers to health care seeking with bothersome lower urinary tract symptoms among men—a nationwide study. Fam Pract. 2019;36(6):743–50. https://doi.org/10.1093/fampra/cmz019.

    Article  Google Scholar 

  13. Hartigan SM, Smith AL. Disparities in female pelvic floor disorders. Curr Urol Rep. 2018;19(2):16. https://doi.org/10.1007/s11934-018-0766-3.

    Article  Google Scholar 

  14. Willis-Gray MG, Sandoval JS, Maynor J, Bosworth HB, Siddiqui NY. Barriers to urinary incontinence care seeking in White, Black, and Latina women. Female Pelvic Med Reconstr Surg. 2015;21(2):83–6. https://doi.org/10.1097/SPV.0000000000000100.

    Article  Google Scholar 

  15. Jackson E, Hernandez L, Mallett VT, Montoya TI. Knowledge, perceptions, and attitudes toward pelvic organ prolapse and urinary incontinence in Spanish-speaking Latinas. Female Pelvic Med Reconstr Surg. 2017;23(5):324–8. https://doi.org/10.1097/SPV.0000000000000393.

    Article  Google Scholar 

  16. Waetjen LE, Xing G, Johnson WO, Melnikow J, Gold EB. Factors associated with reasons incontinent midlife women report for not seeking urinary incontinence treatment over 9 years across the menopausal transition. Menopause. 2018;25(1):29–37. https://doi.org/10.1097/GME.0000000000000943.

    Article  Google Scholar 

  17. Grimes CL, Clare CA, Meriwether KV, Husk K, Rogers RG. Inadequacy and underreporting of study subjects’ race and ethnicity in federally funded pelvic floor research. Am J Obstet Gynecol. 2021;225(5):562.e1-562.e6. https://doi.org/10.1016/j.ajog.2021.08.036.

    Article  Google Scholar 

  18. Newman D et al. Toileting behaviors and lower urinary tract symptoms: a cross-sectional study of diverse women in the United States | Elsevier Enhanced Reader. https://reader.elsevier.com/reader/sd/pii/S2666142X21000345?token=37286AFDA74C08D826DBDED2CE654815D5BF23D48C5C2AEDE4447B555806CE0A53D96F961AB0243C5B3B9BA2F14DFA90&originRegion=us-east-1&originCreation=20220428041921 (Accessed 28 Apr 2022).

  19. Santos T, Miranda I, Nygaard C, Schreiner L, Castro R, Haddad J. Systematic review of oral therapy for the treatment of symptoms of bladder pain syndrome: the Brazilian guidelines. Rev Bras Ginecol Obstet. 2018;40(02):096–102. https://doi.org/10.1055/s-0037-1609049.

    Article  Google Scholar 

  20. Link CL, et al. Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston Area Community Health Survey. J Urol. 2008;180(2):599–606. https://doi.org/10.1016/j.juro.2008.04.009.

    Article  Google Scholar 

  21. Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology Male Study. J Urol. 2013;189(1):141–5. https://doi.org/10.1016/j.juro.2012.08.088.

    Article  Google Scholar 

  22. Dallas KB et al. Demographic differences and disparities in the misdiagnosis of interstitial cystitis/bladder pain syndrome in a National Cohort of VA Patients. Urology. 2021; S0090429521007093. https://doi.org/10.1016/j.urology.2021.07.019.

  23. Dakil SR, Cox M, Lin H, Flores G. Racial and ethnic disparities in physical abuse reporting and child protective services interventions in the United States. J Natl Med Assoc. 2011;103(9–10):926–31. https://doi.org/10.1016/S0027-9684(15)30449-1.

    Article  Google Scholar 

  24. Rashid N, Vassilakis M, Lin KJ, Kristy R, Ng DB. Primary nonadherence to overactive bladder medications in an integrated managed care health care system. JMCP. 2017;23(4):484–93. https://doi.org/10.18553/jmcp.2017.23.4.484.

    Article  Google Scholar 

  25. Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen C-I, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79–95. https://doi.org/10.1016/j.eururo.2013.08.031.

    Article  Google Scholar 

  26. Moskowitz D, Adelstein SA, Lucioni A, Lee UJ, Kobashi KC. Use of third line therapy for overactive bladder in a practice with multiple subspecialty providers—are we doing enough? J Urol. 2018;199(3):779–84. https://doi.org/10.1016/j.juro.2017.09.102.

    Article  Google Scholar 

  27. Martinez Díaz S et al. A community-based education program for overactive bladder in a predominantly minority older female population: a pilot study. Urol Int. 2022;1–8. https://doi.org/10.1159/000522646.

  28. Lee UJ, et al. National trends in the surgical management of urinary incontinence among insured women, 2004 to 2013: the Urologic Diseases in America Project. J Urol. 2020;203(2):365–71. https://doi.org/10.1097/JU.0000000000000569.

    Article  Google Scholar 

  29. Abufaraj M, et al. Prevalence and trends in urinary incontinence among women in the United States, 2005–2018. Am J Obstet Gynecol. 2021;225(2):166.e1-166.e12. https://doi.org/10.1016/j.ajog.2021.03.016.

    Article  Google Scholar 

  30. Coyne KS, Margolis MK, Kopp ZS, Kaplan SA. Racial differences in the prevalence of overactive bladder in the United States from the epidemiology of LUTS (EpiLUTS) Study. Urology. 2012;79(1):95–101. https://doi.org/10.1016/j.urology.2011.09.010.

    Article  Google Scholar 

  31. Yates A. Addressing the gender gap in urinary continence care. Br J Community Nurs. 2021;26(5):228–34. https://doi.org/10.12968/bjcn.2021.26.5.228.

    Article  Google Scholar 

  32. Thom DH, et al. Differences in prevalence of urinary incontinence by race/ethnicity. J Urol. 2006;175(1):259–64. https://doi.org/10.1016/S0022-5347(05)00039-X.

    Article  Google Scholar 

  33. Dessie SG, Adams SR, Modest AM, Hacker MR, Elkadry EA. Bladder symptoms and attitudes in an ethnically diverse population. Female Pelvic Med Reconstr Surg. 2016;22(1):37–42. https://doi.org/10.1097/SPV.0000000000000213.

    Article  Google Scholar 

  34. Akbar A, et al. Racial differences in urinary incontinence prevalence and associated bother: the multi-ethnic study of atherosclerosis. Am J Obstet Gynecol. 2021;224(1):80.e1-80.e9. https://doi.org/10.1016/j.ajog.2020.07.031.

    Article  Google Scholar 

  35. Suskind AM, et al. Overactive bladder is strongly associated with frailty in older individuals. Urology. 2017;106:26–31. https://doi.org/10.1016/j.urology.2017.03.058.

    Article  Google Scholar 

  36. • Tellechea L, et al. The effect of social determinants of health on overactive bladder symptom severity. J Urol. 2021;205(5):1415–20. https://doi.org/10.1097/JU.0000000000001545. This study investigated the significant impact that social determinants of health have on overactive bladder symptoms.

    Article  Google Scholar 

  37. • Mckellar K, Bellin E, Schoenbaum E, Abraham N. Prevalence, risk factors, and treatment for overactive bladder in a racially diverse population. Urology. 2019;126:70–5. https://doi.org/10.1016/j.urology.2018.12.021. This study analyzed how race plays a role in the prevalence, access to care, and treatment of overactive bladder.

    Article  Google Scholar 

  38. Zuo SW, English K, Agalliu I, Leegant A, Abraham N. Racial and ethnic differences in urodynamic parameters in women with overactive bladder symptoms. Female Pelvic Med Reconstr Surg. 2020;26(2):141–5. https://doi.org/10.1097/SPV.0000000000000838.

    Article  Google Scholar 

  39. Lee UJ, et al. Prevalence of urinary incontinence among a nationally representative sample of women, 2005–2016: findings from the Urologic Diseases in America Project. J Urol. 2021;205(6):1718–24. https://doi.org/10.1097/JU.0000000000001634.

    Article  Google Scholar 

  40. Jarbøl DE, Haastrup PF, Rasmussen S, Søndergaaard J, Balasubramaniam K. Women’s barriers for contacting their general practitioner when bothered by urinary incontinence: a population-based cross-sectional study. BMC Urol. 2021;21(1):99. https://doi.org/10.1186/s12894-021-00864-x.

    Article  Google Scholar 

  41. Ng KL, Ng KWR, Thu WPP, Kramer MS, Logan S, Yong E-L. Risk factors and prevalence of urinary incontinence in mid-life Singaporean women: the Integrated Women’s Health Program. Int Urogynecol J. 2020;31(9):1829–37. https://doi.org/10.1007/s00192-019-04132-3.

    Article  Google Scholar 

  42. Lee JA, et al. Associations between socioeconomic status and urge urinary incontinence: an analysis of NHANES 2005 to 2016. J Urol. 2020;203(2):379–84. https://doi.org/10.1097/JU.0000000000000542.

    Article  Google Scholar 

  43. Duralde ER, et al. Bridging the gap: determinants of undiagnosed or untreated urinary incontinence in women. Am J Obstet Gynecol. 2016;214(2):266.e1-266.e9. https://doi.org/10.1016/j.ajog.2015.08.072.

    Article  Google Scholar 

  44. Tennstedt SL, Link CL, Steers WD, McKinlay JB. Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey. Am J Epidemiol. 2008;167(4):390–9. https://doi.org/10.1093/aje/kwm356.

    Article  Google Scholar 

  45. Goldman HB, et al. Real-world patterns of care for the overactive bladder syndrome in the United States. Urology. 2016;87:64–9. https://doi.org/10.1016/j.urology.2015.09.025.

    Article  Google Scholar 

  46. Brown O, et al. Disparity of racial/ethnic representation in publications contributing to overactive bladder diagnosis and treatment guidelines. Female Pelvic Med Reconstr Surg. 2021;27(9):541–6. https://doi.org/10.1097/SPV.0000000000000992.

    Article  Google Scholar 

  47. Berger MB, Patel DA, Miller JM, DeLancey JO, Fenner DE. Racial differences in self-reported healthcare seeking and treatment for urinary incontinence in community-dwelling women from the EPI study: Healthcare Seeking for Urinary Incontinence. Neurourol Urodyn. 2011;30(8):1442–7. https://doi.org/10.1002/nau.21145.

    Article  Google Scholar 

  48. Kosilov K, Loparev S, Kuzina I, Kosilova L, Prokofyeva A. Socioeconomic status and health-related quality of life among adults and older with overactive bladder. Int J Qual Health Care. 2019;31(4):289–97. https://doi.org/10.1093/intqhc/mzy163.

    Article  Google Scholar 

  49. Davenport A, Stark S, Quian A, Sheyn D, Mangel J. A patient-centered approach to refractory overactive bladder and barriers to third-line therapy. Obstet Gynecol. 2019;134(1):141–8. https://doi.org/10.1097/AOG.0000000000003320.

    Article  Google Scholar 

  50. Kinlaw AC, Jonsson Funk M, Conover MM, Pate V, Markland AD, Wu JM. Impact of new medications and $4 generic programs on overactive bladder treatment among older adults in the United States, 2000–2015. Med Care. 2018;56(2):162–70. https://doi.org/10.1097/MLR.0000000000000858.

    Article  Google Scholar 

  51. Kirby AC, Park S, Cook SB, Odem-Davis K, Gore JL, Wolff EM. Practice patterns for women with overactive bladder syndrome: time between medications and third-line treatments. Female Pelvic Med Reconstr Surg. 2020;26(7):431–6. https://doi.org/10.1097/SPV.0000000000000811.

    Article  Google Scholar 

  52. Escobar CM, et al. Rethinking second-line therapy for overactive bladder to improve patient access to treatment options. Obstet Gynecol. 2021;137(3):454–60. https://doi.org/10.1097/AOG.0000000000004279.

    Article  Google Scholar 

  53. Carlson KV, Rovner ES, Nair KV, Deal AS, Kristy RM, Schermer CR. Factors associated with improvements in patient-reported outcomes during mirabegron or antimuscarinic treatment of overactive bladder syndrome: a registry study (PERSPECTIVE). Adv Ther. 2019;36(8):1906–21. https://doi.org/10.1007/s12325-019-00994-7.

    Article  Google Scholar 

  54. Hall SA, Link CL, Hu JC, Eggers PW, McKinlay JB. Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int. 2009;104(11):1680–8. https://doi.org/10.1111/j.1464-410X.2009.08686.x.

    Article  Google Scholar 

  55. Davidson ERW, Miceli L, Propst K. Why patients fall through the cracks: assessment of patients’ overactive bladder treatment. J Women’s Health. 2022; jwh.2021.0635. https://doi.org/10.1089/jwh.2021.0635.

  56. Syan R, Zhang CA, Enemchukwu EA. Racial and socioeconomic factors influence utilization of advanced therapies in commercially insured OAB patients: an analysis of Over 800,000 OAB patients. Urology. 2020;142:81–6. https://doi.org/10.1016/j.urology.2020.04.109.

    Article  Google Scholar 

  57. Dobberfuhl AD, Mahal A, Dallas KB, Choi KM, Comiter CV, Elliott CS. Statewide success of staged sacral neuromodulation for the treatment of urinary complaints in California (2005–2011). Female Pelvic Med Reconstr Surg. 2020;26(7):437–42. https://doi.org/10.1097/SPV.0000000000000605.

    Article  Google Scholar 

  58. Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu E. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation Technol Neural Interface. 2019;22(6):738–44. https://doi.org/10.1111/ner.12981.

    Article  Google Scholar 

  59. Mamza JB, et al. Geographical variation in rates of surgical treatment for female stress urinary incontinence in England: a national cohort study. BMJ Open. 2019;9(8):e029878. https://doi.org/10.1136/bmjopen-2019-029878.

    Article  Google Scholar 

  60. Toye F, Barker KL. A meta-ethnography to understand the experience of living with urinary incontinence: ‘is it just part and parcel of life?’ BMC Urol. 2020;20(1):1. https://doi.org/10.1186/s12894-019-0555-4.

    Article  Google Scholar 

  61. Mckellar K, Abraham N. Prevalence, risk factors, and treatment for women with stress urinary incontinence in a racially and ethnically diverse population. Neurourol Urodyn. 2019;38(3):934–40. https://doi.org/10.1002/nau.23930.

    Article  Google Scholar 

  62. Dallas KB, Sohlberg EM, Elliott CS, Rogo-Gupta L, Enemchukwu E. Racial and socioeconomic disparities in short-term urethral sling surgical outcomes. Urology. 2017;110:70–5. https://doi.org/10.1016/j.urology.2017.08.021.

    Article  Google Scholar 

  63. Syan R, Dallas KB, Sohlberg E, Rogo-Gupta L, Elliott CS, Enemchukwu EA. Rates and risk factors for future stress urinary incontinence surgery after pelvic organ prolapse repair in a large population-based cohort in California. Urology. 2019;123:81–6. https://doi.org/10.1016/j.urology.2018.09.008.

    Article  Google Scholar 

  64. Gomelsky A, Dmochowski RR. Treatment of mixed urinary incontinence. cejurol3/2011. 2011;64:120–6. https://doi.org/10.5173/ceju.2011.03.art2.

    Article  Google Scholar 

  65. Forde JC, Chughtai B, Cea M, Stone BV, Te A, Bishop TF. Trends in ambulatory management of urinary incontinence in women in the United States. Female Pelvic Med Reconstr Surg. 2017;23(4):250–5. https://doi.org/10.1097/SPV.0000000000000365.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Dalhousie University, Halifax, NS, Canada

    Wyatt MacNevin, Christopher Bitcon & Ashley Cox

Authors
  1. Wyatt MacNevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Bitcon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashley Cox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashley Cox.

Ethics declarations

Conflict of Interest

Wyatt MacNevin and Chris Bitcon declare no conflict of interests related to this work. Ashley Cox has received honoraria from Abbvie-Allergan but has no conflicts of interest directly related to this work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Outcomes in Functional Urology

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

MacNevin, W., Bitcon, C. & Cox, A. Social Disparities in the Diagnosis and Care of Lower Urinary Tract Dysfunction. Curr Bladder Dysfunct Rep 17, 271–278 (2022). https://doi.org/10.1007/s11884-022-00673-4

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-022-00673-4

Keywords

Search

Navigation